Cerebral monitoring during transcarotid artery revascularization with flow reversal via transcranial doppler ultrasound examination.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
01 2021
Historique:
received: 18 10 2019
accepted: 26 03 2020
pubmed: 26 4 2020
medline: 4 5 2021
entrez: 26 4 2020
Statut: ppublish

Résumé

Transcarotid artery revascularization (TCAR) is a hybrid technique for carotid artery revascularization that relies on proximal carotid occlusion with flow reversal for distal embolic protection. The hemodynamic response of the intracranial circulation to flow reversal is unknown. In addition, the rate and pattern of cerebral embolization during flow reversal has yet to be investigated. The aim of this study was to characterize cerebral hemodynamic and embolization patterns during TCAR. A single-institution retrospective study of patients with carotid artery stenosis undergoing TCAR with intraoperative transcranial Doppler (TCD) monitoring of the middle cerebral artery (MCA) was performed. Primary outcomes included changes in MCA velocity and MCA embolic signals observed throughout TCAR. Eleven patients underwent TCAR with TCD monitoring of the ipsilateral MCA. The average MCA velocity at baseline was 50.6 ± 16.4 cm/s. MCA flow decreased significantly upon initiation of flow reversal (50.5 ± 16.4 cm/s vs 19.1 ± 18.4 cm/s; P = .02). The reinitiation of antegrade flow resulted in a significant increase in the number of embolic events compared with baseline (P = .003), and embolic events were observed in two patients during flow reversal. TCD monitoring of patients undergoing TCAR revealed that the initiation of flow reversal results in a decrement in ipsilateral MCA velocity. Furthermore, embolic events can occur during flow reversal and are significantly associated with the reinitiation of antegrade flow in the internal carotid artery. However, both of these hemodynamic events were well-tolerated in our cohort. These findings suggest that TCAR remains a safe neuroprotective strategy for carotid revascularization.

Identifiants

pubmed: 32334047
pii: S0741-5214(20)31051-X
doi: 10.1016/j.jvs.2020.03.051
pmc: PMC7577965
mid: NIHMS1587144
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-131

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002554
Pays : United States

Informations de copyright

Copyright © 2020 Society for Vascular Surgery. All rights reserved.

Références

J Neurosurg. 1994 Jul;81(1):15-9
pubmed: 7911520
J Neurosurg. 1993 Sep;79(3):379-82
pubmed: 8360734
J Vasc Surg. 2001 Mar;33(3):504-9
pubmed: 11241119
Lancet Neurol. 2010 Apr;9(4):353-62
pubmed: 20189458
J Vasc Surg. 1997 Dec;26(6):973-9; discussion 979-80
pubmed: 9423712
J Ultrasound Med. 2017 Mar;36(3):621-630
pubmed: 28127789
J Endovasc Ther. 2017 Apr;24(2):265-270
pubmed: 28335706
J Vasc Surg. 1995 Jun;21(6):963-9
pubmed: 7776476
Stroke. 1998 Oct;29(10):2038-42
pubmed: 9756578
Ultraschall Med. 2015 Aug;36(4):337-41
pubmed: 24963921
J Vasc Surg. 2011 Nov;54(5):1317-23
pubmed: 21658889
J Vasc Surg. 2015 Nov;62(5):1227-34
pubmed: 26506270
Eur J Vasc Surg. 1992 Mar;6(2):142-7
pubmed: 1572454
J Vasc Surg. 2019 Jun;69(6):1786-1796
pubmed: 30611582

Auteurs

Lindsey A Olivere (LA)

Duke University School of Medicine, Durham, NC.

James Ronald (J)

Department of Interventional Radiology, Duke University Medical Center, Durham, NC.

Zachary Williams (Z)

Department of Surgery, Duke University Medical Center, Durham, NC.

Mitchell W Cox (MW)

Department of Surgery, Duke University Medical Center, Durham, NC.

Chandler Long (C)

Department of Surgery, Duke University Medical Center, Durham, NC.

Cynthia K Shortell (CK)

Department of Surgery, Duke University Medical Center, Durham, NC.

Kevin W Southerland (KW)

Department of Surgery, Duke University Medical Center, Durham, NC. Electronic address: kevin.southerland@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH